Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advancements in Cardiovascular Research and Therapeutics
| Advancements in Cardiovascular Research and Therapeutics |
| Autore | Sathibabu V. V |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Sharjah : , : Bentham Science Publishers, , 2022 |
| Descrizione fisica | 1 online resource (233 pages) |
| Altri autori (Persone) | NaiduParim Brahma |
| Soggetto topico | MEDICAL / Cardiology |
| Soggetto non controllato |
Cardiology
Medical |
| ISBN |
9789815050837
9815050834 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Cardiovascular Diseases and Nutraceuticals: Underlying Mechanism and Therapeutic Biomarkers -- Pallavi Saxena1, Vinod Kumar2, Noopur Khare3, Neeraj Pal4, Dibyabhaba Pradhan5, Pradeep K Chaturvedi2, Arun Kumar Jain1, Manoj Kumar6, V. V. Sathibabu Uddandrao7 and Umesh Kumar8,* -- 1. INTRODUCTION -- 1.1. Cardiovascular Disorders -- 1.2. Cardiovascular Diseases Burden: Global and National -- 1.3. Potential Risk Factors for CVD -- 1.4. Therapies in Use for CVD Treatment -- 1.4.1. ACE Inhibitors -- 1.4.2. Angiotension II Receptor Blockers -- 1.4.3. Antiarrhythmics -- 1.4.4. Antiplatelet Drugs -- 1.4.5. M. Anti-coagulants Drugs -- 1.4.6. Diuretics -- 2. NUTRACEUTICALS AND CARDIOVASCULAR HEALTH -- 2.1. Nutraceuticals -- 2.2. Potential Nutraceuticals -- 2.2.1. Plant Sterols/ Stanols -- 2.2.2. Cruciferous Vegetables -- 2.2.3. Garlic -- 2.2.4. CoQ10 -- 2.2.5. Turmeric -- 2.2.6. Grape Skin -- 2.2.7. Fish Oil/Olive Oil -- 2.2.8. Vegetables -- 2.2.9. Carnitine -- 2.2.10. Berberine -- 2.2.11. Flavonoids -- 2.2.12. Prebiotics -- 2.2.13. Probiotics -- 2.2.14. Protein and Protein Peptides -- 2.2.15. Vitamins -- 3. NUTRACEUTICALS MODULATE GENETIC EXPRESSION -- 3.1. NF-κB Regulatory Network -- 3.2. Nrf2 Regulates Antioxidant and Detoxification Genes -- 4. BIOINFORMATICS APPLICATION IN NUTRACEUTICALS AND CVD PREVENTION -- 4.1. Identification of New Therapeutic Biomarkers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Congestive Heart Failure: Insight on Pharmacotherapy -- Sri Bharathi G.S1,*, Sakthi Sundaram S1, Prabhakaran S1, Lalitha V1, Haja Sherief S1, Duraisami R2 and Sengottuvelu S1 -- 1. INTRODUCTION -- 1.1. Hypertrophic Cardiomyopathy (HCM) -- 1.2. Left Ventricular Noncompaction (LVNC).
1.3. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) -- 1.4. Restrictive Cardiomyopathy (RCM) -- 2. PREVALENCE -- 3. PATHOPHYSIOLOGY -- 4. DRUG THERAPY -- 4.1. Diuretics -- 4.2. Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors) -- 4.3. Beta-adrenergic Blocking Agents (Beta Blockers) -- 4.4. Vasopressin Receptor Antagonists -- 5. MANAGEMENT OF HEART FAILURE -- 5.1. Acute Decompensation -- 5.2. Chronic Management -- 5.3. Palliative Care -- 5.4. Cardiac Glycosides -- 5.4.1. Chemistry of Cardiac Glycosides -- 5.4.2. Sources of Cardiac Glycosides -- 5.4.3. Mechanism of Cardiac Glycosides -- 5.4.4. Pharmacological Activity of Cardiac Glycosides -- 6. DIGOXIN -- 7. TOXICOKINETICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Diet, Inflammation and Cardiovascular Disorders -- M Kesavan1,* and HV Manjunathachar2,* -- 1. INTRODUCTION -- 1.1. Diet Induced Inflammation -- 1.2. Dietary Inflammatory Index (DII) -- 2. DIFFERENT PATTERNS OF DIET AND THEIR CHARACTERISTICS -- 2.1. The Zone Diet -- 2.2. Ketogenic Diet -- 2.3. Mediterranean Diet -- 2.4. DASH (Dietary Approaches to Stop Hypertension) Diet -- 2.5. The Paleo Diet -- 2.6. Vegan and Vegetarian Diet -- 3. CARDIOVASCULAR DISEASES (CVD), PRO AND ANTI-INFLAMMATORY AGENTS -- 4. SPICES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Rodent and Non-Rodent Animal Models for CardioVascular Diseases -- Irfan Ahmad Mir1,*, HV Manjunathachar1,*, R Ravindar Naik1, SSYH Qadri2 and Taniya Saleem3 -- 1. RODENT MODELS FOR CVD -- 2. ATHEROSCLEROSIS AND DIABETIC MODELS -- 2.1. LDLR−/− Mice -- 2.2. ApoE−/− Mice -- 2.3. SR-BI KO Mice -- 2.4. db/db Mouse -- 2.5. Ob/ob Mice -- 2.6. Zucker Fatty Rat -- 2.7. Zucker Diabetic Fatty (ZDF) Rat -- 2.8. Otsuka Long-Evans Tokushima fatty (OLETF) Rats. 2.9. Goto-Kakizaki (GK) Rats -- 2.10. WNIN/GR-Ob Rat -- 3. HEART FAILURE MODELS -- 3.1. Myocardial Ischemia-Induced Heart Failure -- 3.2. Pressure Overload Models -- 3.3. Chemical-induced Cardiomyopathy Models -- 4. NON-RODENT MODELS OF CARDIO-VASCULAR DISEASES -- 4.1. Overview of Advantages and Disadvantages of Non-rodent Animal Models -- 4.2. Pigs -- 4.3. Atherosclerotic Disease Models -- 4.4. Pig Models for Stent Application -- 4.5. Pig Models of Infarction and Heart Failure -- 4.6. Dogs -- 4.7. Sheep -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of 21st Century Genetic Engineering Tools and CRISPR-Cas9 Technologies to Treat Most Advanced Cardiovascular Diseases of Humans -- J. Venkateshwara Rao1, *, R. Ravindar Naik2, S. Venkanna1 and N. Ramesh Kumar3 -- 1. INTRODUCTION -- 2. THE CRISPR/CAS9 PROTEIN TECHNOLOGY -- 3. APPLICATION OF CRISPR/CAS9 TECHNOLOGY AS A THERAPEUTIC TOOL FOR HUMAN DISEASES -- 3.1. Cystic Fibrosis (CF) -- 3.2. Sickle Cell Anemia -- 3.3. Thalassemia -- 3.4. Huntington's Disease -- 3.5. Duchenne Muscular Dystrophy -- 3.6. Hemophilia -- 3.7. Chronic Granulomatous Disorders (CGD) -- 4. MULTIFACTORIAL DISEASES -- 4.1. Cancer -- 4.2. Cardiovascular Diseases (CVD) -- 5. APPLICATIONS OF CRISPR/CAS9 IN CARDIAC RESEARCH -- 5.1. Gene Therapy for CVD -- 5.2. The Future of CRISPR/Cas9 Genome Editing in Cardiac Research -- 6. CHALLENGES OF APPLICATION OF CRISPR/CAS9 -- 6.1. Delivery Systems of CRISPR/Cas9 -- 6.2. Off-target Effects -- 6.3. Ethical Issues -- 6.4. Emerging CRISPR Technologies -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Role of Vyana Vayu in CardioVascular System, Etiopathogenesis and Therapeutic Strategies: An Ayurveda Perspective. Savitri Vasudev Baikampady1,*, C. S. Hiremath1, Reeta Varyani1 and Venketesh2 -- 1. INTRODUCTION -- 2. A PREAMBLE TO VATA -- 2.1. Vyana Vayu -- 2.1.1. Role of Vyana Vayu in the Heart -- 2.1.2. Role of Vyana Vayu in Vasculature (Dhamani and Sira) -- 2.1.3. Role of Vyana Vayu in Skeletal Muscles and other Organs -- 3. ETIOLOGY -- 4. PATHOGENESES -- 4.1. Stage of Accumulation (Sanchaya) -- 4.2. Stage of Aggravation (Prakopa) -- 4.3. Stage of Dissemination (Prasar) -- 4.4. Stage of Localization (Sthanasamshraya) -- 4.5. Stage of Manifestation (Vyakta) -- 4.6. Stage of Complication (Bheda) -- 5. CONCOMITANT CONCEPT -- 6. CLINICAL IMPLICATIONS -- 7. TREATMENT STRATEGIES -- 7.1. Diet -- 7.2. Exercise -- 7.3. Pharmacological Approach -- 7.3.1. Terminalia Arjuna (TA) -- 7.3.2. Innula Recemosa -- 7.3.3. Fagonia Arabica -- 8. OMICS STUDY AND AYURVEDIC THERAPEUTIC STRATEGIES -- CONCLUSION -- 10. HIGHLIGHTS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Nutraceuticals: The Potential Agents to Rescue Human Race from Cardiovascular Diseases (CVDs) -- Sreedevi Gandham1, Ghali. EN.Hanuma Kumar2 and Balaji Meriga2,* -- 1. INTRODUCTION -- 2. CVDS: PATHOPHYSIOLOGY -- 3. CVDS: TREATMENT OPTIONS -- 4. PLANTS AND HERBS FOR TREATMENT OF CVDS -- 4.1. Polyphenols -- 4.2. Flavonoids -- 4.3. Carotenoids -- 4.4. Other Phytochemicals -- 4.5. Vitamins -- 5. NUTRACEUTICALS TO TREAT CVDS -- 6. SPICES AS EFFECTIVE NUTRACEUTICALS TO TREAT CVDS -- 6.1. Ginger (Zingiber Officinale) -- 6.2. Turmeric (Curcuma Longa) -- 6.3. Black pepper (Piper Nigrum) -- 6.4. Coriander (Coriandrum Sativum) -- 6.5. Cinnamon (Cinnamomum Zeylanicum) -- 6.6. Garlic (Allium Sativum) -- 6.7. Cloves (Syzygium Aromaticum) -- 6.8. Other Common Spices -- 7. NUTRACEUTICALS/SPICES: MODE OF ACTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST. ACKNOWLEDGEMENTS -- REFERENCES -- Ameliorative Potential of Biochanin-A against Dexamethasone Induced Hypertension through Modulation of Relative mRNA and Protein Expressions in Experimental Rats -- V. V. Sathibabu Uddandrao1,*, P. P. Sethumathi2, Parim Brahma Naidu3, S. Vadivukkarasi1, Mustapha Sabana Begum4 and G. Saravanan1,* -- 1. INTRODUCTION -- 2. MATERIALS AND METHODS -- 2.1. Chemicals -- 2.2. Animals -- 2.3. Induction of Hypertension -- 2.4. Experimental Design -- 2.5. Measurement of Body Weight -- 2.6. Indirect Measurement of Blood Pressure in Conscious Rats -- 2.7. Hemodynamic and Vascular Responsiveness Measurements -- 2.8. Assay of Nitric Oxide Metabolites -- 2.9. Assay of Superoxide Production -- 2.10. RT-PCR Analysis -- 2.11. Western Blot Analysis -- 2.12. Statistical Analysis -- 3. RESULTS -- 4. DISCUSSION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Zingiberene, an Active Constituent from Zingiber officinale Ameliorated High-Fat Diet-Induced Obesity Cardiomyopathy in Rats -- S. Jaikumar1, G. Somasundaram1 and S. Sengottuvelu2,* -- 1. INTRODUCTION -- 2. MATERIALS AND METHODS -- 2.1. Chemicals -- 2.2. Animals -- 2.3. HFD Composition -- 2.4. Experimental Design -- 2.5. Measurement of Body Weight, Anthropometrical and Morphological Parameters -- 2.6. Estimation of Biochemical Markers -- 2.7. Determination of Cardiac Lipid Profile -- 2.8. Assessment of Oxidative Stress Markers in Heart -- 2.9. Statistical Analysis -- 3. RESULTS -- 3.1. Effect of ZB on Anthropometrical and Morphological Parameters -- 3.2. Influence of ZB on Diabetic Markers -- 3.3. Effect of ZB on Cardiac Lipid Profiles -- 3.4. ZB Ameliorated Oxidative Stress in Heart -- 4. DISCUSSION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES. Betaine, a Nutraceutical Ameliorated Myocardial Infarction by Attenuation of Pro-Inflammatory Cytokines and Matrix Metalloproteinase Production in Rats. |
| Altri titoli varianti | Advancements in Cardiovascular Research and Therapeutics |
| Record Nr. | UNINA-9911069638503321 |
Sathibabu V. V
|
||
| Sharjah : , : Bentham Science Publishers, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of the Chest, Breast, Heart and Vessels 2019-2022 [[electronic resource] ] : Diagnostic and Interventional Imaging / / edited by Juerg Hodler, Rahel A. Kubik-Huch, Gustav K. von Schulthess
| Diseases of the Chest, Breast, Heart and Vessels 2019-2022 [[electronic resource] ] : Diagnostic and Interventional Imaging / / edited by Juerg Hodler, Rahel A. Kubik-Huch, Gustav K. von Schulthess |
| Autore | Hodler Juerg |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham, : Springer Nature, 2019 |
| Descrizione fisica | 1 online resource (VIII, 238 p. 137 illus., 25 illus. in color.) |
| Disciplina | 616.0757 |
| Collana | IDKD Springer Series |
| Soggetto topico |
Radiology
Respiratory organs—Diseases Oncology Cardiology Imaging / Radiology Pneumology/Respiratory System Oncology |
| Soggetto non controllato |
Medicine
Radiology Respiratory organs—Diseases Oncology Cardiology |
| ISBN | 3-030-11149-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. A Systematic Approach to Chest Radiographic Analysis (Klein, J., L. Rosado-de-Christenson, M.) -- Chapter 2. Missed Lung Lesions: Side by Side Comparison of Chest Radiography with MDCT (Tack, D., Howarth, N.) -- Chapter 3. Approach to Imaging of Mediastinal Conditions in the Adult (Bhalla, S., Marom, E.) -- Chapter 4. Plain Film and HRCT Diagnosis of Interstitial Lung Disease (Desai, S., Galvin, J., Prosch, H.) -- Chapter 5. CT Diagnosis and Management of Focal Lung Disease (Abbott, G., Vlahos, I.).-Chapter 6. Current Approach to Acute and Chronic Airway Disease (Grenier, P., Kanne, J.) -- Chapter 7. Imaging of Pulmonary Infections (Franquet, T., Chung, J.) -- Chapter 8. Current Concepts in Diagnosis and Staging of Lung Cancer (Carter, B., Erasmus, J.) -- Chapter 9. Diseases of the Chest Wall Pleura and Diaphragm (Kelly, A., Frauenfelder, T.) -- Chapter 10. Pediatric Chest Disorders (Hart, A., Lee, E.) -- Chapter 11. Chest Manifestations of Systemic Disease (Schaefer-Prokop, C., Elicker, B.) -- Chapter 12. Thoracic Trauma (Ketai, L., Primack, S.) -- Chapter 13. Diagnosis and Staging of Breast Cancer: When and How to Use Mammography, Tomosysthesis and Ancillary Imaging Techniques (Gilbert, F., Comstock, C., Pinker-Domenig, K.) -- Chapter 14. Follow up of Patients with Breast Cancer: Imaging of Local Recurrence and Distant Metastases (Bick, U., Helbich, T.) -- Chapter 15. CT & MRI of Suspected Ischemic Heart Disease (including CTA) (De Roos, A., Nikolaou, K.) -- Chapter 16. Imaging of Non-ischemic Cardiomyopathy (Bluemke, D., Teague, S.) -- Chapter 17. Modern Diagnosis in the Evaluation of Pulmonary Vascular Disease (Bankier, A., Dennie, C.) -- Chapter 18. Imaging of Acute Aortic Syndrome (Grist, T., Rubin, G.) -- Chapter 19. Pre-and Post Aortic Endovascular Intervention: What a Radiologist Needs to Know (Bley, T., Roos, J.) -- Chapter 20. Non-invasive Angiography of Peripheral Arteries (Leiner, T., Carr, J.). |
| Record Nr. | UNINA-9910337524403321 |
|
Hodler Juerg
|
||
| Cham, : Springer Nature, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Endoscopic mitral valve surgery [[electronic resource] ] : handbook of minimal-invasive cardiac surgery / / Ralf Krakor
| Endoscopic mitral valve surgery [[electronic resource] ] : handbook of minimal-invasive cardiac surgery / / Ralf Krakor |
| Autore | Krakor Ralf <1963-> |
| Pubbl/distr/stampa | Berlin, : Walter de Gruyter, c2012 |
| Descrizione fisica | 1 online resource (148 p.) |
| Disciplina | 617.4/120597 |
| Soggetto topico |
Mitral valve - Surgery
Heart - Surgery Endoscopic surgery |
| Soggetto non controllato |
Cardiology
Endoscopic Mitral Valve Surgery Minimally Invasive Cardiac Surgery Mitral Valve Reconstruction |
| ISBN | 3-11-025445-X |
| Classificazione | YI 8000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Anesthesiology and pain management -- Technical prerequisites -- Preparations -- Valve repair techniques -- Tips and tricks -- Additional procedures. |
| Record Nr. | UNINA-9910791968203321 |
|
Krakor Ralf <1963->
|
||
| Berlin, : Walter de Gruyter, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Endovascular Interventions : A Step-By-Step Approach / / edited by Jose M. Wiley [and three others]
| Endovascular Interventions : A Step-By-Step Approach / / edited by Jose M. Wiley [and three others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley-Blackwell, , [2023] |
| Descrizione fisica | 1 online resource (275 pages) |
| Disciplina | 617.4130597 |
| Soggetto topico | Blood-vessels - Endoscopic surgery |
| Soggetto non controllato |
Cardiology
Medical |
| ISBN |
1-119-46777-2
1-119-46784-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Chapter 1 Innominate & -- Carotid Artery Intervention in High-Risk Patients -- Introduction -- Innominate Interventions in High-Risk Patients -- Catheter-based Therapy for An Innominate (Brachiocephalic) Stenosis -- Carotid Artery Intervention in High-Risk Patients -- Endovascular Treatment of A Carotid Stenosis -- Catheter-based Therapy for Carotid Stenosis -- Conclusions -- References -- Chapter 2 Subclavian Artery Intervention: Catheter-Based Therapy -- Introduction -- Endovascular Versus Open Surgical Revascularization -- Endovascular Revascularization Techniques -- Conclusion -- References -- Chapter 3 Vertebral Artery Intervention: Catheter-Based Therapy -- Introduction -- Preprocedural Considerations -- Step 1. Procedural Planning with Diagnostic Angiography -- Step 2. Vertebral Artery Intervention (Percutaneous Transluminal Angioplasty) -- Step 3. Vertebral Artery Intervention (Stenting) -- Management of Potential Complications -- Postprocedural Care -- References -- Chapter 4 Endovascular Repair of Thoracic Aortic Aneurysms: Catheter-Based Therapy -- Introduction -- Relevant Anatomy -- Aortic Anatomy -- Crawford Classification for TAA/TAAA -- Landing Zones (Figure 4.1) -- Indications/Contraindications to Procedure -- Indications -- Contraindications/Caveats -- Available Endografts -- Preoperative Evaluation -- Positioning and Intraoperative Monitoring Needs -- Procedural Steps -- Postoperative Course/Surveillance -- Monitored Setting -- Spinal Drain -- Blood Pressure Control -- Arm Ischemia Symptoms -- CTA Surveillance/Endoleak Types -- References -- Chapter 5 Endovascular Abdominal Aortic Aneurysm Repair (EVAR) -- Introduction -- Patient Selection -- Preoperative Imaging and Measurements -- Graft Selection -- Graft Sizing -- Neck Length -- Neck Diameter.
Branch Vessels -- Aortic Length Measurements -- Step 1. Vascular Access -- Percutaneous -- Open -- Iliac Disease and Conduits -- Step 2. Imaging -- Equipment -- Neck Angulation -- Renal Arteries -- Step 3. Wires -- Step 4. Delivery and Deployment -- Main Body -- Contralateral Gate Cannulation -- Limb Deployment -- Completion Angiogram -- Step 5. Troubleshooting -- Endoleaks -- Inadvertent Coverage of Renal Arteries -- Iliac Artery Considerations -- Conclusion -- References -- Chapter 6 Severe Renal Artery Stenosis: How to Intervene -- Introduction -- Background and Clinical Significance -- Epidemiology -- Clinical Manifestations -- Patient Selection: Who to Screen for RAS -- RAS Assessment -- Noninvasive RAS Assessment -- Invasive RAS Assessment -- Indications for Revascularization -- Intervention -- References -- Chapter 7 Mesenteric Ischemia: Chronic and Acute Management -- Introduction -- Chronic Mesenteric Ischemia -- Step 1. Vascular Access and Sheath Selection -- Step 2. Diagnostic Angiography -- Step 3. Vessel Selection -- Step 4. Selective Angiography -- Step 5. Placement of a Working Wire -- Step 6. Stent Placement -- Step 7. Posttreatment Angiography -- Step 8. Revision -- Complications -- Follow-Up and Outcomes -- Acute Mesenteric Ischemia -- Step 1. Arterial Vascular Access and Sheath Selection -- Step 2. Selection of the SMA -- Step 3. Aspiration Embolectomy -- Step 4. Angiogram -- Step 5. Thrombolysis -- Step 6. Infusion and Follow-Up -- Mesenteric Venous Thrombosis -- Follow-Up and Outcomes -- References -- Chapter 8 Aorto-Iliac Interventions -- Introduction -- Preoperative Workup -- Noninvasive Studies -- Computed Tomographic Angiography -- Ultrasound Duplex -- Magnetic Resonance Angiography -- Invasive Imaging -- Angiography -- Classification of Lesion and Planning of Intervention. TransAtlantic InterSociety Consensus II Classification (TASC II) -- Planning for the Intervention -- Step 1. Patient Factors -- Step 2. Vascular Access -- Step 3. Crossing the Lesion -- Step 4. Intervention -- Step 5. Closure -- Step 6. Complications -- Rupture -- Embolization -- Access Complications -- Cases -- Case 1 -- Case 2 -- References -- Chapter 9 Femoropopliteal Arterial Interventions in the Claudicant -- Introduction -- Patient Evaluation and Indications for Treatment of Femoropopliteal Arterial Pathology -- Indications for Revascularization Femoropopliteal Claudication -- Vascular Imaging in Endovascular Treatment -- Contrast Angiography -- CO2 Angiography -- Extravascular and Intravascular Ultrasound -- Vascular Access and Lesion Crossing Techniques -- Steps for Crossover "Up and Over" technique -- Radial -- Tibio-Pedal Approach -- Antegrade Femoral Access -- Working Wire Size and Changing Between Systems -- Lesion Preparation -- Atherectomy -- Directional Atherectomy -- Orbital Atherectomy -- Embolic Protection -- Troubleshooting Embolic Protection Devices -- Stenting for Femoropopliteal Disease -- Alternative Stent Technologies -- Conclusions -- Acknowledgments -- References -- Chapter 10 Tibial Interventions in Patients with Critical Limb-Threatening Ischemia -- Introduction -- Indications and Goals of Endovascular Revascularization -- Considerations for Access Site -- Single Versus Multitibial Artery Revascularization -- Antegrade Tibial Artery Intervention -- Retrograde Access for Retrograde Lesion Crossing and Wire Externalization with Antegrade Revascularization -- TAMI Retrograde Revascularization -- Reentry and Externalization Devices -- Deep Venous Arterialization (DVA) -- References -- Chapter 11 Acute Limb Ischemia: Endovascular Approach -- Introduction -- Procedure Planning, Equipment, and Considerations -- References. Chapter 12 Pedal Reconstruction -- Introduction -- Pedal Arch Reconstruction -- Indications for Pedal Revascularization -- Technical Considerations -- Access -- Lesion Crossing -- CTO Lesion Subtype -- Special Considerations of the Pedal Intervention -- Troubleshooting -- Summary -- References -- Chapter 13 Endovascular Management of Access Site Complications -- Introduction -- Complications Related to Common Femoral Artery Access -- Access Site Bleeding -- Crossover Technique -- Balloon Tamponade, Endovascular Coiling, and Covered Stent Placement -- Femoral Pseudoaneurysms -- Ultrasound-Guided Compression Repair -- Ultrasound-Guided Thrombin Injection -- Covered Stent Placement -- Other Techniques -- Arteriovenous Fistulas -- Vascular Closure Device Related Complications -- Radial Artery Related Complications -- Radial Artery Spasm -- Radial Artery Occlusion -- Bleeding Complications -- References -- Chapter 14 Acute Deep Vein Thrombosis -- Introduction -- Treatment Strategy -- Initial and Long-Term Treatment of VTE -- Oral Anticoagulants -- Thrombolysis -- Vena Cava Filters -- Compression Stockings -- Cancer-Associated VTE -- Isolated Distal DVT -- Extended Treatment -- Unprovoked VTE -- Oral Anticoagulants -- Conclusion -- References -- Chapter 15 Lower-Extremity Venous Stenting -- Introduction -- Follow-Up -- References -- Chapter 16 Intervention for Pulmonary Embolism -- Introduction -- Pulmonary Angiography -- Vascular Access -- Injection and X-Ray Detector Positioning -- Catheter-Directed Thrombolysis -- EKOS™ Catheter-Directed Thrombolysis -- Preparation of System -- Access -- Mechanical Disruption -- Catheter Fragmentation of Clot -- Large Catheter Aspiration -- FlowTriever™ -- Access -- Penumbra -- AngioVac -- Patient Selection and Central Venous Access -- AngioVac Circuit Setup and Thrombus Aspiration -- AngioVac for Clot-in-Transit. AngioVac for Right Heart Vegetation -- Patient Selection and Approach -- Technique -- References -- Chapter 17 Catheter-Based Therapy for Varicose Veins -- Introduction -- Thermal Techniques -- Radiofrequency (RF) Ablation -- Follow-Up -- Endovenous Laser Ablation (EVLA) -- Nonthermal Techniques -- Mechanico-Chemical Ablation (MOCA) -- Limitations -- Summary -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910831021803321 |
| Hoboken, NJ : , : Wiley-Blackwell, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modelling the human cardiac fluid mechanics. 3rd ed
| Modelling the human cardiac fluid mechanics. 3rd ed |
| Autore | Oertel HerbertKrittian, SebastianSpiegel, Kathrin |
| Pubbl/distr/stampa | KIT Scientific Publishing, 2009 |
| Descrizione fisica | 1 online resource (80 p. p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
Cardiology
Flow Simulation Fluid Mechanics Heart Surgery Human Heart |
| ISBN | 1000011015 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346925403321 |
|
Oertel HerbertKrittian, SebastianSpiegel, Kathrin
|
||
| KIT Scientific Publishing, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Primary Angioplasty [[electronic resource] ] : A Practical Guide / / edited by Timothy J Watson, Paul JL Ong, James E Tcheng
| Primary Angioplasty [[electronic resource] ] : A Practical Guide / / edited by Timothy J Watson, Paul JL Ong, James E Tcheng |
| Autore | Watson Timothy J |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore, : Springer Nature, 2018 |
| Descrizione fisica | 1 online resource (XIV, 338 p. 134 illus., 80 illus. in color.) |
| Disciplina | 616.12 |
| Soggetto topico | Cardiology |
| Soggetto non controllato |
Medicine
Cardiology |
| ISBN | 981-13-1114-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword -- Historical perspectives on management of acute myocardial infarction -- Pre-hospital diagnosis and management of acute myocardial infarction -- STEMI network and logistics – rural vs. urban -- Cath lab design, staffing, training -- Patient preparation and vascular access for primary PCI -- Management of intra-coronary thrombus -- Culprit only artery versus multi-vessel disease -- Pharmacologic therapies in primary PCI – antiplatelet agents -- Pharmacologic therapies in primary PCI – glycoproteins, heparins, bivalirudins, etc -- Pharmacologic therapies in primary PCI – inotropes, etc -- Drug-eluting stents vs. bare-metal stents in Primary PCI - Is there still a debate? -- Drug-eluting balloons in primary PCI -- High bleeding risk scenarios in primary PCI -- Mechanical complications of myocardial infarction – free-wall rupture, VSD, acute MR -- The role of mechanical circulatory support in primary PCI – IABP, ECMO, IMPELLA, LUCAS? -- Methods of reducing infarct size and reperfusion injury in primary PCI -- Time to reperfusion, door to balloon times, and how to reduce them -- Utilization of facilitated and rescue angioplasty in primary PCI -- Primary angioplasty: the economics -- Role of bypass surgery in acute myocardial infarction: indications, timing, outcome -- Role of intravascular imaging in emergency PCI -- Patients ineligible for primary PCI . |
| Record Nr. | UNINA-9910300318003321 |
|
Watson Timothy J
|
||
| Singapore, : Springer Nature, 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||